5-methyl-4-(4-phenoxyanilino)-6-(4-phenyl-1,4-diazepane-1-carbonyl)pyrrolo[1,2-b]pyridazine-3-carbonitrile
C33H30N6O2 — CID 143026399
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-methyl-4-(4-phenoxyanilino)-6-(4-phenyl-1,4-diazepane-1-carbonyl)pyrrolo[1,2-b]pyridazine-3-carbonitrile
5-methyl-4-(4-phenoxyanilino)-6-(4-phenyl-1,4-diazepane-1-carbonyl)pyrrolo[1,2-b]pyridazine-3-carbonitrile (PubChem CID 143026399) has the molecular formula C33H30N6O2 and a molecular weight of 542.64 g/mol. Its IUPAC name is 5-methyl-4-(4-phenoxyanilino)-6-(4-phenyl-1,4-diazepane-1-carbonyl)pyrrolo[1,2-b]pyridazine-3-carbonitrile.
Molecular Properties
| Compound Name | 5-methyl-4-(4-phenoxyanilino)-6-(4-phenyl-1,4-diazepane-1-carbonyl)pyrrolo[1,2-b]pyridazine-3-carbonitrile |
|---|---|
| PubChem CID | 143026399 |
| Molecular Formula | C33H30N6O2 |
| Molecular Weight | 542.64 g/mol |
| Exact Mass | 542.24 |
| IUPAC Name | 5-methyl-4-(4-phenoxyanilino)-6-(4-phenyl-1,4-diazepane-1-carbonyl)pyrrolo[1,2-b]pyridazine-3-carbonitrile |
| SMILES | Cc1c(C(=O)N2CCCN(c3ccccc3)CC2)cn2ncc(C#N)c(Nc3ccc(Oc4ccccc4)cc3)c12 |
| InChI | InChI=1S/C33H30N6O2/c1-24-30(33(40)38-18-8-17-37(19-20-38)27-9-4-2-5-10-27)23-39-32(24)31(25(21-34)22-35-39)36-26-13-15-29(16-14-26)41-28-11-6-3-7-12-28/h2-7,9-16,22-23,36H,8,17-20H2,1H3 |
| InChIKey | BCXRVWMRBJYZIB-UHFFFAOYSA-N |
| XLogP | 6.40 |
| TPSA | 85.90 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 542.64 |
| LogP ≤ 5 | 6.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143026399 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.